FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Somerset Nitrofurantoin Oral Suspension Recall

Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by:…

LUPIN SOMERSET · Somerset, NJ

Risk level
Class II
Reported by FDA
Jan 9, 2019
Recall ID
D-0346-2019
Check your lot numberHow we source this data

Summary

Lupin Somerset recalled Nitrofurantoin Oral Suspension starting Dec 21, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0346-2019 on Jan 9, 2019. Reason: Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay. Status: Terminated.

Why it was recalled

Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.

Product description

Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, NDC 43386-450-11.

Lot numbers, UPCs & expiration codes

Lot #: S700038, S700044, S700059, S700065, Exp 28-Feb-19; S700410, S700427, Exp 30-Jun-19; S700617, S700619, Exp 31-Aug-19; S700813, S700815, S700869, Exp 31-Oct-19; S700871, S700873, Exp 30-Nov-19; S700875, S701073, Exp 31-Dec-19.

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0346-2019
Classification
Class II
Status
Terminated
Recall initiated
Dec 21, 2018
FDA report date
Jan 9, 2019
Quantity
23,460 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
LUPIN SOMERSET

Original FDA data

Every field from FDA enforcement report D-0346-2019, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
81865
Address
400 Campus Dr
Code information
Lot #: S700038, S700044, S700059, S700065, Exp 28-Feb-19; S700410, S700427, Exp 30-Jun-19; S700617, S700619, Exp 31-Aug-19; S700813, S700815, S700869, Exp 31-Oct-19; S700871, S700873, Exp 30-Nov-19; S700875, S701073, Exp 31-Dec-19.
Postal code
08873-1145
Report date
Jan 9, 2019
Product type
Drugs
Recall number
D-0346-2019
Classification
Class II
Recalling firm
LUPIN SOMERSET
Product quantity
23,460 bottles
Termination date
Mar 15, 2023
Reason for recall
Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, NDC 43386-450-11.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Dec 21, 2018
Initial firm notification
Letter
Center classification date
Dec 31, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0346-2019, published Jan 9, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls